Akriti Pharmaceuticals Private Limited, a active private limited company, was established on 14 November 2003 in Thane West, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2003PTC143136. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 169 professional, Its leadership includes Jitendra Prasad (Director), Priyanka Prasad (Director). Past directors included Madhurendra Kumar, Jitendra Prasad, Madhurendra Vashist Narayan Singh Kumar. It holds ₹7.80 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 205, Thane Mint, India Bulls, Behind Hiranandani Meadows, Near Hyde Park,, Thane West, Maharashtra, 400610.
U24230MH2003PTC143136
143136
14 November 2003
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Akriti Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendra Prasad | Director | 07 Sep 2015 | Current |
| Priyanka Prasad | Director | 14 Nov 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 07 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Akriti Pharmaceuticals Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Akriti Pharmaceuticals had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹78,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2024 | Hdfc Bank Limited | ₹4.50 Cr | Open |
| 21 Nov 2022 | Others | ₹1.20 Cr | Open |
| 11 Apr 2015 | Kotak Mahindra Bank Limited | ₹2.10 Cr | Open |
Explore comprehensive loan charge details -
Akriti Pharmaceuticals has a workforce of 169 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Akriti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akriti Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Akriti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Hdfc Bank Limited of Rs. 45.00 M registered on 04 Mar 2024 with Charge ID 100899905 was modified on 14 Aug 2024. was completed.
Progress on Akriti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 45.00 M with Charge ID 100899905 was registered on 04 Mar 2024. was completed.
A charge with Others amounted to Rs. 12.00 M with Charge ID 100641472 was registered on 21 Nov 2022. was recorded as a recent event.
The activity Jitendra Prasad was appointed as a Director was appointed as a Director on 07 Sep 2015 & has been associated with this company since 10 years 2 months . was completed.
The CIN of Akriti Pharmaceuticals Private Limited is U24230MH2003PTC143136.
Akriti Pharmaceuticals Private Limited is headquartered at Office No. 205, Thane Mint, India Bulls, Behind Hiranandani Meadows, Near Hyde Park,, Thane West, Maharashtra, 400610.
Akriti Pharmaceuticals Private Limited was incorporated on 14 November 2003.
The current directors of Akriti Pharmaceuticals Private Limited are
The primary industry of Akriti Pharmaceuticals Private Limited is Manufacturing.
Akriti Pharmaceuticals Private Limited is unlisted.
The authorized capital of Akriti Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Akriti Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX